Navigation Links
Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress
Date:11/5/2013

tember 30, 2013 ResultsTotal operating expenses for the third quarter of 2013 were $65.5 million, compared with total operating expenses of $54.9 million for the comparable period in 2012.

Product revenue for the nine months ended September 30, 2013 was $192.1 million, compared with $173.5 million for the nine months ended September 30, 2012, an increase of 11 percent. Total revenue for the nine months ended September 30, 2013 was $192.8 million, compared with $174.7 million for the same period in 2012. 

Net loss was $3.4 million for the nine months ended September 30, 2013, compared with net income of $6.3 million for the nine months ended September 30, 2012. 

Cash and cash equivalents and short-term investments at September 30, 2013 were $114.0 million, compared with $99.1 million at December 31, 2012. 

In the third quarter, more than 21,790 Oncotype DX test results were delivered, an increase of 21 percent, compared with more than 18,030 test results delivered in the same period in 2012.

Recent Business Highlights:Oncotype DX Commercial Progress

  • The National Institute for Health and Care Excellence (NICE) in the United Kingdom issued final guidance recommending Oncotype DX as the only multi-gene breast cancer test for use in clinical practice to guide chemotherapy treatment decisions for patients with early-stage, hormone receptor-positive, invasive breast cancer.
  • Established node-positive and ductal carcinoma in situ (DCIS) coverage for approximately 1.3 million U.S. lives through a contract with a large Blue Cross Blue Shield state plan.
  • Medical Meeting Presentations, Publications and Pipeline

  • The Journal of Clinical Oncology accepted for publication positive results from the third successful validation of the Oncotype DX colon cancer test in patients with stage II disease and the first validation study in patients with stage III disease.  '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. New MTHFR Gene Test Extends Holistic Pharmacogenomics Approach to Treating Depression
    2. Genomic Health to Announce Third Quarter 2013 Financial Results and Host Conference Call on Tuesday, November 5, 2013
    3. Extensive Scientific Data Supports the Clinical Validity of Pharmacogenomic Testing for Predicting Patient Response to Psychiatric Medications
    4. Life Technologies Ion Torrent Breakthrough Award Honors Discoveries and Genomic Research Fueled by Next-Generation Sequencing
    5. BioNano Genomics Raises $10 Million Financing To Advance Irys System For Human Genome Analysis
    6. Global Genomics Group (G3) and Illumina to Partner on Cardiovascular Genomics
    7. S&P Capital IQ Initiates Coverage on Epigenomics AG in Standard & Poors Factual Stock Reports
    8. Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market is Expected to Grow to USD 52.3 Billion Globally by 2019: Transparency Market Research
    9. Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic
    10. Genomic Health to Present at the Canaccord Genuity 33rd Annual Growth Conference
    11. Genomic Health Announces Second Quarter 2013 Financial Results and Business Progress
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
    (Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
    (Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex ... it will report its second quarter 2015 financial results ... a conference call and live webcast at 4:30 p.m. ... clinical development programs and a general corporate update. ... the Investor Relations page of the OncoGenex website at ...
    Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
    ... Corporation,(Nasdaq: IOMI ) today announced that interim results ... patch-based vaccine for travelers, diarrhea,found that all subjects who ... -- mounted an immune response, demonstrating that even elderly,subjects ... The trial was designed to compare the number of ...
    ... N.C., Aug. 10 More than 33% ... identify clinical,investigators 50% faster than their industry ... clinical trial costs while improving quality,by employing ... to research probing clinical trial excellence by,pharmaceutical ...
    Cached Medicine Technology:Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 2Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 3Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 4Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management 2
    (Date:8/1/2015)... ... 02, 2015 , ... Back packs can be dangerous? Whaaat?! , Not the ... wreck havoc on a kid's spine. With school starting again, most kids will be ... sure you are aware of how to help them prevent injuries by understanding backpack ...
    (Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins ... men and women often causing pain and discomfort. Those who spend a lot of ... and Northeast Houston Vein Center is doing what it can to create awareness and ...
    (Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of the ... of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what has ... both companies have agreed to join their missions of purpose together to change the ...
    (Date:8/1/2015)... ... ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 to ... , The app is designed to track various metrics of wellness, including physical activity, ... health and use this information for positive behavior modification. Lume Wellness keeps track of ...
    (Date:8/1/2015)... ... ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction ... stepping off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 ... greeted by friends and family. He visited CCAR and left an inspirational message to ...
    Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2
    ... ... ... ... ...
    ... ... ... , ... ...
    ... ... ... ... ...
    ... shown to be effective in breast cancer packs an effective ... a specific genetic mutation, a study at UCLA,s Jonsson Comprehensive ... when given together proved to significantly inhibit tumor growth in ... mutation that results in an aggressive form of the disease, ...
    ... scientists studying acute forms of Leukaemia have identified a new ... the growth of diseased cells. The research, reported in ... to genes, which if targeted could prevent diseased cells from ... the University of Vienna, carried out their research on acute ...
    ... bone mineral density, strength and postural balance due to ... group of women but also for elderly men, says ... and continues "It is well known that the risk ... result of weaker bones, poorer balance and attenuated ability ...
    Cached Medicine News:Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 2Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 3Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 4Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 5Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 6Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 7Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 8Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 9Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 10Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 11Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 12Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 13Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 14Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 15Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 16Health News:Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request 17Health News:Marketech Celebrates 25 Years of Service 2Health News:Marketech Celebrates 25 Years of Service 3Health News:Marketech Celebrates 25 Years of Service 4Health News:Marketech Celebrates 25 Years of Service 5Health News:Herceptin and Tykerb effective against a subset of gastric cancers 2Health News:Herceptin and Tykerb effective against a subset of gastric cancers 3Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2Health News:Soccer reduces risk of falls and bone fractures 2Health News:Soccer reduces risk of falls and bone fractures 3
    Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
    Malaria device / strip (3 line, P.f/P.v Ag Test-pLDH)...
    High sensitive, specific one step immunochromatographic assay for human infectious disease...
    High sensitive, specific one step immunochromatographic assay for human infectious disease...
    Medicine Products: